Users Discontinuing Slimming Medications Regain Pounds Four Times Faster Compared to People Using Diet and Exercise

Fresh analysis indicates that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Published data in a leading health publication demonstrates that while overweight people can lose about a fifth of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.

"People using such medications must be informed of the danger of rapid weight regain when the medication is stopped," stated expert Dr. Susan Jebb.

This pace of regain suggests a reversion to starting mass within about a year and a half.

Weighing Approaches

The analysis, which looked at 37 of trials involving thousands of participants, compared the results of these new drugs with other pills.

Researchers point out that people who lose weight through diet and exercise typically experience a less rapid creep back—approximately 100 grams monthly—after stopping.

The Reason for the Quick Regain

Nutrition scientists believe the mode of action of the drugs accounts for the heightened weight return.

GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the system to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating far more likely."

An Ongoing Issue?

Health authorities advise the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

A number of clinicians argue that, given the likelihood of relapse, the therapy might need to be long-term.

This view is echoed by drug manufacturers, who say that the results "emphasize the persistent character of excess weight," comparing it to managing diseases like diabetes.

User Accounts

Individuals who have stopped the jabs explain a sudden resurgence of appetite.

"It felt as if a switch flipping and I was suddenly extremely hungry," said an individual.

This difficulty is exacerbated if individuals have not adopted lasting lifestyle or habit changes during therapy.

Growing Use

Recent estimates show that millions of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.

• Use is greater among females than men.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the medications through private healthcare rather than public health services.

Finally, researchers stress that while these medications are effective tools for shedding pounds, they are not a permanent fix and long-term success relies on ongoing lifestyle support.